Clinical Trials
6
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study
- Conditions
- Chronic Kidney Disease stage4
- Interventions
- Drug: KT-301 (formerly US-APR2020)
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Kibow Pharma
- Target Recruit Count
- 600
- Registration Number
- NCT05407389
- Locations
- 🇺🇸
Jadedstone Clinical Research, Silver Spring, Maryland, United States
🇺🇸Kidney Michigan, Saginaw, Michigan, United States
🇺🇸South Carolina Clinical Research, Orangeburg, South Carolina, United States
Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV
- First Posted Date
- 2021-06-04
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Kibow Pharma
- Target Recruit Count
- 630
- Registration Number
- NCT04913272
- Locations
- 🇺🇸
Jadedstone Clinical Research, Silver Spring, Maryland, United States
🇺🇸Kidney Michigan, Saginaw, Michigan, United States
🇺🇸South Carolina Clinical Research, Orangeburg, South Carolina, United States
Observational Study of Kibow Biotics in Chronic Kidney Failure Patients
- Conditions
- Chronic Kidney Failure
- First Posted Date
- 2011-10-12
- Last Posted Date
- 2017-08-18
- Lead Sponsor
- Kibow Pharma
- Target Recruit Count
- 31
- Registration Number
- NCT01450657
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Observational Study of Kibow Biotics in Dialysis Patients
- Conditions
- Chronic Kidney Failure
- First Posted Date
- 2011-10-12
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Kibow Pharma
- Target Recruit Count
- 30
- Registration Number
- NCT01450670
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Observational Study of Kibow Biotics in Chronic Kidney Failure Patients on Dialysis
- Conditions
- Chronic Kidney Disease
- First Posted Date
- 2011-10-12
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Kibow Pharma
- Target Recruit Count
- 30
- Registration Number
- NCT01450709
- Locations
- 🇺🇸
Parkside Dialysis Clinic at Downstate Medical Center, Brooklyn, New York, United States
- Prev
- 1
- 2
- Next